| Bioactivity | 2′,2′-Difluorodeoxyuridine-13C,15N2 (dFdU-13C,15N2; 2',2'-Difluoro-2'-deoxyuridine-13C,15N2) is a 13C- and 15N-labeled compound. |
| Invitro | 氢、碳和其他元素的稳定重同位素已被纳入药物分子中，主要作为药物开发过程中定量的示踪剂。氘化引起了人们的关注，因为它可能影响药物的药代动力学和代谢谱[1]。 |
| Name | 2′,2′-Difluorodeoxyuridine-13C,15N2 |
| CAS | 1233921-75-9 |
| Formula | C813CH10F215N2O5 |
| Molar Mass | 267.16 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019 Feb;53(2):211-292. |
2′,2′-Difluorodeoxyuridine-13C,15N2
CAS: 1233921-75-9 F: C813CH10F215N2O5 W: 267.16
2′,2′-Difluorodeoxyuridine-13C,15N2 (dFdU-13C,15N2; 2',2'-Difluoro-2'-deoxyuridine-13C,15N2) is a 13C- and 15N-labeled
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.